Dordaviprone
Last Updated: 11/08/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 54 publications
Histone-modifying Enzymes as Therapeutic Targets in Glioma: Biological Rationale and Translational Findings.
Journal: Hematology/oncology clinics of North America
Published: October 06, 2026
PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs in Japan; tovorafenib and dordaviprone for glioma, mirvetuximab soravtansine and pembrolizumab for ovarian cancer, tislelizumab for nasopharyngeal cancer, trastuzumab deruxtecan, palbociclib and datopotamab deruxtecan for breast cancer, epcoritamab for lymphoma, teclistamab for multiple myeloma.
Journal: International journal of clinical oncology
Published: October 03, 2026
Recent Advances in the Classification and Treatment of Pediatric Gliomas
Journal: No shinkei geka. Neurological surgery
Published: August 16, 2026
Interpretable Machine Learning Prognostic Model Integrating Inflammatory-Nutritional Biomarkers for Post-Prostatectomy Biochemical Recurrence: Development, Internal Validation, and Translational Target Exploration.
Journal: Current oncology (Toronto, Ont.)
Published: August 03, 2026
Molecular Tumor Board: H3K27M Diffuse Midline Glioma Diagnosed During Pregnancy by Cerebrospinal Fluid Next-Generation Sequencing.
Journal: The oncologist
Published: July 04, 2026
Molecular tumor board: H3K27M diffuse midline glioma diagnosed during pregnancy by cerebrospinal fluid next-generation sequencing.
Journal: The oncologist
Published: July 04, 2026
Mitochondrial CLPP in Health and Disease: Mechanisms, Therapeutic Duality and Emerging Opportunities.
Journal: Journal of inherited metabolic disease
Published: June 25, 2026
QSAR-Guided Virtual Screening and Molecular Dynamics Reveal Olaparib as a Repurposing Lead Against α-Synuclein Aggregation.
Journal: International journal of molecular sciences
Published: June 24, 2026
Adult Thalamic Diffuse Midline Glioma, H3 K27-Altered, With KRAS Comutation and Potential Early Subependymal Dissemination.
Journal: Journal of medical cases
Published: June 24, 2026
H3K27M-mutant diffuse midline glioma pharmacotherapy: Clinical evidence and practice implications of dordaviprone.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: June 19, 2026
Last Updated: 11/08/2026